Should the periosteum be incised at the orbital rim to release the arcus marginalis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Arcus Marginalis Release Technique

Yes, the periosteum must be incised at the orbital rim to properly release the arcus marginalis, and this requires direct contact with the bony orbital rim. This is a well-established surgical principle in lower eyelid and midface rejuvenation procedures.

Technical Approach

The arcus marginalis release requires a specific sequence of steps that involves periosteal incision:

  • The periosteum at the orbital rim must be incised to release the arcus marginalis attachment, which is the fibrous connection between the orbital septum and the periosteum along the inferior orbital rim 1, 2.

  • Direct visualization and palpation of the bony orbital rim is necessary during this procedure to ensure complete release of the arcus marginalis 1.

  • The incision is made directly at the periosteum overlying the infraorbital rim, typically using cautery cutting to release the arcus marginalis 1.

Surgical Rationale

The anatomical basis for this technique is clear:

  • The arcus marginalis represents the attachment point where the orbital septum fuses with the periosteum at the inferior orbital rim 2.

  • Without incising the periosteum and releasing this attachment, orbital fat cannot be advanced beyond the infraorbital rim to achieve the desired aesthetic result 2.

  • A supraperiosteal pocket is created below the orbicularis oculi muscle after the arcus marginalis release, which requires working directly on the bony surface 1.

Clinical Evidence

Multiple studies demonstrate the necessity of periosteal incision:

  • In a prospective study of 20 young Asian patients, the technique specifically involved extending dissection over the arcus marginalis and releasing it by cautery cutting at the periosteum, with 90% excellent results and no major complications 1.

  • A 152-case series over 3 years confirmed that arcus marginalis release is accomplished at the periosteal level, allowing subseptal fat to be advanced and sutured beyond the entire infraorbital rim 2.

  • The technique has been successfully employed in 85 cases with direct undermining of the arcus marginalis at the surface of the orbicularis, confirming the need for periosteal manipulation 3.

Important Caveats

  • The periosteal incision should be precise and controlled to avoid unnecessary trauma to surrounding structures 1.

  • Blunt dissection is used to create the supraperiosteal pocket after the initial periosteal incision, minimizing bleeding and tissue damage 1.

  • This is distinct from oncologic surgery where periosteum serves as an anatomical barrier; in soft tissue sarcoma surgery, periosteum is recognized as a "resistant anatomical barrier" that can serve as an adequate margin 4.

Related Questions

In an adult undergoing lower‑eyelid or mid‑face rejuvenation, after incising the periosteum at the orbital rim to release the arcus marginalis, how can the dissection be continued inferiorly in the supraperiosteal plane rather than the subperiosteal plane?
After an arcus marginalis release, does dissecting on the bony surface to create a supraperiosteal pocket place the dissection in the subperiosteal plane?
In an adult patient undergoing lower‑eyelid or mid‑face rejuvenation, should the periosteum be incised down to the bony surface of the orbital rim to release the arcus marginalis?
Is the fat redistributed after complete release of the tear‑trough (orbicularis‑retaining) ligament placed in the supraperiosteal or subperiosteal plane, and how can damage to the infraorbital nerve be avoided?
What is the recommended first‑line filler treatment for a patient with smoker’s lines, including product choice, injection technique, volume, and pre‑procedure smoking cessation advice?
Can oral iron supplementation be taken concurrently with a proton‑pump inhibitor, or should the doses be spaced?
A patient receiving continuous intravenous vancomycin for several weeks has developed a rash on the abdomen and legs; what is the appropriate management?
What are the recommended next steps for a 34‑year‑old female with Ehlers‑Danlos syndrome (EDS), mast cell activation syndrome (MCAS), postural orthostatic tachycardia syndrome (POTS), borderline low immunoglobulin G (IgG) and low‑normal immunoglobulin A (IgA), recurrent otitis media with tympanic membrane perforations, persistent oral ulceration, and non‑immune measles‑mumps‑rubella (MMR) measles and mumps titers?
Is it normal for a hypothyroid patient over‑replaced with levothyroxine for five months (suppressed TSH, normal free T4) and taking candesartan (candesartan cilexetil) 8 mg twice daily for hypertension to develop tremor, severe anxiety, and suicidal ideation?
What over‑the‑counter supplements are recommended for an adult to lower LDL cholesterol?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.